We have previously reported evidence that Nogo-A activation of Nogo-receptor 1 (NgR1) can drive axonal dystrophy during the neurological progression of experimental autoimmune encephalomyelitis (EAE). The gene discussed is RTN4R; the disease is experimental autoimmune encephalomyelitis.